January 16, 2018
Midatech conducts study on childhood brain cancer drug in USA
Midatech Pharma will conduct a study of an investigational new drug for the treatment of the fatal childhood brain cancer…
Pharmaceuticals, Biotechnology and Life Sciences
Tag: Midatech
July 26, 2017
Midatech wraps up pre-clinical liver cancer programm, human studies in 2018
Midatech Pharma has prepared its candidate MTD119 (previously MTR104) for advanced liver cancer for the clinical testings, in a pre-clinical programme that included three subcutaneous or orthotopic liver cancer xenograft models treated with the active cytotoxic compound maytansine conjugated with Midatech’s gold nanoparticle (GNP) technology.
February 27, 2017
Midatech borrows £6 million
Midatech has borrowed £6 million from Silicn Valley Bank to add to the placing of the shares it made in October last year.
January 5, 2016
Midatech in vaccines collaboration with Emergex
Midatech Pharma, the international specialty pharmaceutical company focused on developing and commercialising products in oncology and other therapeutic areas, has entered into a licensing agreement with Emergex Vaccines Limited, a private UK biotechnology company focused on infectious diseases utilising Midatech’s gold nanoparticle technology.